17p deletion in acute myeloid leukemia and myelodysplastic syndrome. Analysis of breakpoints and deleted segments by fluorescence in situ

Blood

Volumn 91, Issue 3, 1998, Pages 1008-1015

  Soenen, Valérie ^b   Preudhomme, Claude ^b   Roumier, Christophe ^b   Daudignon, Agnès ^b   Laï, Jean Luc ^b   Fenaux, Pierre ^a  

^a CHU Rouen BG   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BLAST TRANSFORMATION; CHROMOSOME 17P; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CHROMOSOME PAINTING; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE REARRANGEMENT; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MONOSOMY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

EID: 0032006824     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.3.1008.1008_1008_1015     Document Type: Article

References (30)

1. Fenaux P: Myelodysplastic syndromes. Hematol Cell Ther 38: 363, 1996
2. Mufti GJ, Path MRC: A guide to risk assessment in the primary myelodysplastic syndrome. Hematol Oncol Clin North Am 6:587, 1992
3. Fenaux P, Morel P, Laï JL: Cytogenetics of myelodysplastic syndromes. Semin Hematol 33:127, 1996
4. Nowell PC: Chromosome abnormalities in myelodysplastic syndromes. Semin Oncol 19:25, 1992
5. Pierre RV, Catovsky D, Mufti GJ: Clinical-cytogenetic correlations in myelodysplasias (preleukemia). Cancer Genet Cytogenet 40:149, 1989
6. Laï JL, Zandecki M, Fenaux P, Le Baron F, Bauters F, Cosson A, Deminatti M: Translocations (5;17) and (7;17) in patients with de novo or therapy-related myelodysplastic syndromes or acute nonlymphocytic leukemia. A possible association with acquired pseudo-Pelger-Huët anomaly and small vacuolated granulocytes. Cancer Genet Cytogenet 46:173, 1990
7. Laï JL, Preudhomme C, Zandecki M, Flactif M, Vanrumbeke M, Wattel E, Fenaux P: Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoiesis and a high incidence of P53 mutations. Leukemia 9:370, 1995
8. Fenaux P, Jonveaux P, Quiquandon I, Laï JL, Pignon JM, Loucheux-Lefebvre MH, Bauters F, Berger R, Kerckaert JP: P53 gene mutations in acute myeloid leukemia with 17p monosomy. Blood 78:1652, 1991
9. Jonveaux P, Fenaux P, Pignon JM, Laï JL, Quiquandon I, Kerckaert JP, Loucheux-Lefebvre MH, Goossens M, Bauters F, Berger R: Mutation in the p53 gene in myelodysplastic syndrome. Oncogene 6:2243, 1991
10. Sessarego M, Ajmar F: Correlation between acquired pseudo-Pelger-Huët anomaly and involvement of chromosome 17 in chronic myeloid leukemia. Cancer Genet Cytogenet 25:265, 1987
11. Ahuja H, Bar Eli E, Arlin Z: The spectrum of molecular alterations in the evolution of the chronic myelocytic leukemia. J Clin Invest 87:2042, 1991
12. Jary L, Mossafa H, Fourcade C, Genet P, Pulik M, Flandrin G: The 17p-syndrome: A distinct myelodysplastic syndrome entity? Leuk Lymphoma 25:163, 1997
13. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick H, Sultan C: Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189, 1982
14. Mitelman F (ed): International System for Cytogenetic Nomenclature: Guidelines for Cancer Cytogenetics, Supplement to an International System for Human Cytogenetic Nomenclature. Basel, Switzerland, Karger, 1995
15. Chumakov MI, Rigault P, Le Gall I, Bellanné-Chantelot C, Billault A: A YAC contig map of the human genome. Nature 377:175, 1995 (suppl)
16. Wiegnant J, Galjart NJ, Raap AK, d'Azzo A: The gene encoding human protective protein (PPGB) is on the chromosome 20. Genomics 10:345, 1991
17. Chaffanet M, Imbert A, Adélaïde J, Le Paslier D, Wagner MJ, Wells DE, Birnbaum D, Pébusque MJ: A 3.1-Mb YAC contig within the Werner syndrome region, on the short arm of human chromosome 8. Cytogenet Cell Genet 72:63, 1996
18. Lepelley P, Preudhomme P, Vanrumbeke M, Quesnel B, Cosson A, Fenaux P: Detection of P53 mutation in hematological malignancies: Comparison between immunocytochemistry and DNA analysis. Leukemia 8:1342, 1994
19. Mitelman F: Catalog of Chromosomes Aberrations in Cancer (ed 5). New York, NY, Wiley-Liss, 1994
20. Rubin CM, Arthur DC, Woods WG, Lange BJ, Nowell PC, Rowley JD, Nachman J, Bostrom B, Baum ES, Suarez CR, Shah NR, Morgan E, Maurer HS, McKenzie SE, Larson RA, Le Beau MM: Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children: Correlation between chromosomal abnormalities and prior therapy. Blood 78:2982, 1991
21. Stuppia L, Palka G, Fioritoni G, Calabrese G, Guanciali Franchi P, d'Aracangelo L, Torlontano G: Karyotypic changes identified by HaeIII restriction endonuclease banding in a patient with M2 acute non-lymphoblastic leukemia. Genes Chromosomes Cancer 1:310, 1990
22. Novak A, Jankovic G, Rolovic Z: Two karyotypically unrelated clones with the t(5;17) and deletion of 5q in myelodysplastic syndrome. Cancer Genet Cytogenet 62:100, 1992
23. Baer MR, Sreekantaiah C, Jani Sait SN, Sawyer AM, Block AMW, Sandberg AA, Preisler HD: Cytogenetic study of maturing granulocytes in bone marrow of patients with acute myelogenous leukemia. Leukemia 4:297, 1990
24. Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, Golomb HM, Rowley JD: Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute non lymphocytic leukemia: Further evidence for characteristic abnormalities of chromosomes no5 and 7. J Clin Oncol 4:325, 1986
25. Jonveaux P, Derré J, Berger R: Whole arm translocation t(17;18): A non-random abnormality of myeloid cell proliferation. Leukemia 7:1987, 1993
26. Van Den Berghe H, Vermaelen K, Mecucci C: The 5q-anomaly. Cancer Genet Cytogenet 17:189, 1985
27. Pedersen-Bjergaard J, Philip P: Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II. Blood 78:1147, 1991
28. Takahashi T, Carbone D, Takahashi T, Nau MM, Hida T, Linnoila I, Ueda R, Minna JD: Wild-type but not mutant P53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions. Cancer Res 52:2340, 1992
29. Sander CA, Yano T, Clark HM, Harris C, Longo DL, Jaffe ES, Raffeld M: P53 mutation is associated with progression in follicular lymphoma. Blood 82:1994, 1993
30. Wattel E, Preudhomme C, Hecquet B, Vanrumbeke M, Quesnel B, Dervite A, Morel P, Fenaux P: P53 mutation associated to resistance to chemotherapy and short survival in hematological malignancies. Blood 84:3148, 1994